Clinical Trial Update: Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the safety and efficacy of bosentan in patients with diastolic heart failure and secondary pulmonary hypertension has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Pulmonary Hypertension

Drugs mentioned

• TRACLEER (bosentan)

Snippet

Sponsor: University Teaching Hospital Hall in Tirol | Conditions: Heart Failure, Diastolic, Hypertension, Pulmonary | Phase 3 | Status: COMPLETED